Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
The high-tech procedure enabled surgeons to remove a cancerous tumor from the patient’s prostate remotely. The 60-year-old ...
Results show excellent early functional recovery in clinically complex patients with advanced prostate cancer ... Read More The post Orthocell nerve repair product Remplir shows promise in prostate ...
For patients whose cancer is localized to one area, the procedure can offer an alternative to radiation or surgery. During treatment, physicians insert thin cryoneedles into the prostate and use ...
MINNEAPOLIS, April 21, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company based in Maple Grove, Minn., today announced that Aaron Milbank, MD., of Minnesota Urology ...
After receiving a prostate cancer diagnosis and experiencing the many emotions that can come with it, deciding on a course of treatment can be overwhelming. It’s daunting to want to make the right ...
Early results of a randomized clinical trial evaluating a new prostate cancer treatment are promising, say Yale physician-scientists who are part of the international study. The trial, known as ...
A national study of more than 20,000 men with localized prostate cancer found that surgery was linked to higher rates of urinary incontinence and erectile dysfunction, while radiation therapy was ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results